Massimo Puoti
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 169
- Hepatitis C virus research 162
- Liver Disease and Transplantation 18
- Epidemiology 119
- Hepatitis B Virus Studies 74
- Liver Disease Diagnosis and Treatment 66
- Co-authors
- Heiner Wedemeyer (6 shared papers)Francesco Negro (5 shared papers)Geoffrey Dusheiko (3 shared papers)Alessio Aghemo (13 shared papers)Marina Berenguer (4 shared papers)Olav Dalgård (2 shared papers)Fiona Marra (2 shared papers)Jean–Michel Pawlotsky (3 shared papers)
- Journals
- Journal of Hepatology (30 papers)Digestive and Liver Disease (22 papers)Liver International (11 papers)AIDS (10 papers)Antiviral Therapy (8 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Puoti
249 papers receiving 9.1k citations
Massimo Puoti's Hit Papers
Peers
Comparison fields: 5 of 128
- Hepatology 6.1k
- Epidemiology 4.8k
- Virology 489
- Infectious Diseases 1.7k
- Emergency Medicine 423
Countries citing papers authored by Massimo Puoti
This map shows the geographic impact of Massimo Puoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Puoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Puoti more than expected).
Fields of papers citing papers by Massimo Puoti
This network shows the impact of papers produced by Massimo Puoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Puoti. The network helps show where Massimo Puoti may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Puoti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 270 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EASL Recommendations on Treatment of Hepatitis C 2018 Hit paper breakdown → | 2018 | 1521 |
| 2 | EASL recommendations on treatment of hepatitis C: Final update of the series☆ Hit paper breakdown → | 2020 | 743 |
| 3 | 1998 | 447 | |
| 4 | 1991 | 288 | |
| 5 | 2007 | 266 | |
| 6 | 2008 | 202 | |
| 7 | 2004 | 195 | |
| 8 | 2000 | 185 | |
| 9 | 2005 | 176 | |
| 10 | 2004 | 174 | |
| 11 | 2001 | 171 | |
| 12 | 2007 | 165 | |
| 13 | 2008 | 164 | |
| 14 | 2008 | 139 | |
| 15 | 2015 | 137 | |
| 16 | 2001 | 134 | |
| 17 | 2005 | 134 | |
| 18 | 2018 | 113 | |
| 19 | 2018 | 102 | |
| 20 | 2003 | 99 |
About Massimo Puoti
Massimo Puoti is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Emergency Medicine, having authored 270 papers that have together received 9.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (162 papers), Hepatitis B Virus Studies (74 papers), Liver Disease Diagnosis and Treatment (66 papers), HIV/AIDS drug development and treatment (35 papers), Liver Disease and Transplantation (18 papers), HIV-related health complications and treatments (13 papers), Systemic Lupus Erythematosus Research (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hepatology (6.1k citations), Epidemiology (4.8k citations), Virology (489 citations), Infectious Diseases (1.7k citations) and Emergency Medicine (423 citations). Massimo Puoti has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Heiner Wedemeyer, Francesco Negro, Geoffrey Dusheiko, Alessio Aghemo, Marina Berenguer, Olav Dalgård, Fiona Marra, Jean–Michel Pawlotsky, Francesco Donato and Vincent Soriano. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Liver International, AIDS and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.